Pseudomonas aeruginosa journal pdf

Strateva , D. Yordanov Published 1 September Biology, Medicine Journal of medical microbiology Pseudomonas aeruginosa is one of the leading nosocomial pathogens worldwide.

Nosocomial infections caused by this organism are often hard to treat because of both the intrinsic resistance of the species it has constitutive expression of AmpC beta-lactamase and efflux pumps, combined with a low permeability of the outer membrane , and its remarkable ability to acquire further resistance mechanisms to multiple groups of antimicrobial agents, including beta-lactams, aminoglycosides and… Expand.

View PDF. Save to Library Save. Create Alert Alert. Share This Paper. Background Citations. Methods Citations. Results Citations. Tables and Topics from this paper. Citation Type. Has PDF. Publication Type. More Filters. Pseudomonas Aeruginosa: Resistance to the Max. Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa. Journal of medical microbiology.

The influence of Imipenem resistant metallo-beta-lactamase positive and negative Pseudomonas aeruginosa nosocomial infections on mortality and morbidity. J Nat Sci Biol Med. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.

J Antimicrob Chemother. Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis. Sci Rep. Cost attributable to nosocomial bacteremia. PLoS One. European Centre for Disease Prevention and Control. Surveillance Report: Antimicrobial resistance surveillance in Europe A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. Antibacterial-resistant Pseudomonas aeruginosa : clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Clin Microbiol Rev. Strateva T, Yordanov D. Pseudomonas aeruginosa — a phenomenon of bacterial resistance. J Med Microbiol. Biochemical characterization of the naturally occurring oxacillinase OXA of Pseudomonas aeruginosa. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Nordmann P, Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa.

Weldhagen GF, Prinsloo A. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect. Walsh TR. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.

Metallo-beta-lactamases: the quiet before the storm? Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla VIM-2 carbapenem-hydrolyzing beta-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site.

Chem Biol. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. The most frequent aminoglycoside resistance mechanisms — changes with time and geographic area: a reflection of aminoglycoside usage patterns? Poole K. Aminoglycoside resistance in Pseudomonas aeruginosa.

Efflux-mediated antimicrobial resistance. Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa : our worst nightmare? Masuda N, Ohya S. Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa.

Lambert PA. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med. Carbapenem activities against Pseudomonas aeruginosa : respective contributions of OprD and efflux systems. Pechere JC, Kohler T. Patterns and modes of beta-lactam resistance in Pseudomonas aeruginosa. Pseudomonas aeruginosa : resistance and therapeutic options at the turn of the new millennium.

Doi Y, Arakawa Y. Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates. Hooper DC. Mechanisms of action and resistance of older and newer fluoroquinolones. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.

Mol Microbiol. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.

Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques.

Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. Evaluation of a new agar medium containing cetrimide, kanamycin and nalidixic acid for isolation and enhancement of pigment production of Pseudomonas aeruginosa in clinical samples.

J Basic Microbiol. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains.

J Clin Microbiol. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Epidemiol Infect. Population genetic analysis of Pseudomonas aeruginosa using multilocus sequence typing.

Basset P, Blanc DS. Fast and simple epidemiological typing of Pseudomonas aeruginosa using the double-locus sequence typing DLST method. Emerging technologies for the clinical microbiology laboratory. Poirel L, Nordmann P. Rapidec carba NP test for rapid detection of carbapenemase producers. J Microbiol Methods. Evaluation of genotypic and phenotypic methods to detect carbapenemase production in gram-negative Bacilli.

Clin Chem. Emerging infections program healthcare-associated, T. Multistate point-prevalence survey of health care-associated infections.

N Engl J Med. Results from a year prospective cohort study show increased mortality associated with bloodstream infections caused by Pseudomonas aeruginosa compared to other bacteria. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome. Spanish Network for Research in Infectious. Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post Hoc analysis of a prospective cohort. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia.

Infect Control Hosp Epidemiol. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. J Infect. Management of adults with hospital-acquired and ventilator-associated pneumonia: clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Tobramycin penetration into epithelial lining fluid of patients with pneumonia. Clin Pharmacol Ther. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.

Pseudomonas aeruginosa in French hospitals between and back to susceptibility. Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am Rev Respir Dis. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Microbiological testing and outcome of patients with severe community-acquired pneumonia.

Severe community-acquired pneumonia: assessment of microbial aetiology as mortality factor. Eur Respir J. Severe community-acquired pneumonia in an intensive care unit: risk factors for mortality. Intern Med. Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa. Infectious Diseases Society of, S.

American Thoracic. American Thoracic, S. Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa : incidence, risk, and prognosis. Arch Intern Med. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.

Aliment Pharmacol Ther. Pseudomonas aeruginosa urinary tract infections in hospitalized patients: mortality and prognostic factors. Ecthyma gangrenosum in the periorbital region in a previously healthy immunocompetent woman without bacteremia.

Indian Dermatol Online J. Practice guidelines for the diagnosis and management of skin and soft tissue infections: update by the Infectious Diseases Society of America. Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatol Online J. Surgical strategies in the management of ecthyma gangrenosum in paediatric oncology patients. Pediatr Surg Int.

Gram negative wound infection in hospitalised adult burn patients — systematic review and metanalysis. Mayhall CG.

The epidemiology of burn wound infections: then and now. The leading causes of death after burn injury in a single pediatric burn center. Eur J Clin Microbiol. Pseudomonas aeruginosa septicaemia in burns. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Infection in burns. Surg Infect Larchmt ; 17 2 —5. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.

Crit Care Med. DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients? Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia. The higher interactions exhibited in aggregates obtained at suboptimal conditions compromised the solubilization yield.

This work provides an approach for the characterization and solubilization of novel reported biologically active aggregates of this amidase. Addresses: 1. E-mail Address: rpacheco deq. Biotechnology Journal. ISSN Related Papers Measuring enzymatic activity of a recombinant amidase using Fourier transform infrared spectroscopy By Amin Karmali. Monoclonal antibodies recognize conformational epitopes on wild-type and recombinant mutant amidases from Pseudomonas aeruginosa By Amin Karmali.

Application of Fourier transform infrared spectroscopy for monitoring hydrolysis and synthesis reactions catalyzed by a recombinant amidase By Amin Karmali.